Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
ZIMLAB | NSE
-2.49
-2.31%
Healthcare
Drug Manufacturers-Specialty & Generic
31/03/2024
05/06/2026
105.12
103.00
107.50
103.00
ZIM Laboratories Limited develops manufactures and supplies generic pharmaceutical and nutraceutical products in India and internationally. The company provides its products in pre- formulation intermediates and finished formulations using modified release patterns in the oral solid dosage forms such as granules pellets taste-masked powders suspensions tablets capsules dry syrup and oral thin films. It offers therapeutics in the areas of urology gastroenterology CNS antibiotics anti-infectives NSAIDs/pain analgesics and vitamins and supplements. ZIM Laboratories Limited was incorporated in 1984 and is based in Nagpur India.
View LessPositive Momentum
Low Market Beta (-0.4 to 0.8)
Value Stock (Price to Book < 3)
Strong Revenue Growth (> 10%)
Microcap (<300M USD)
Weak Operating Margin (< 10%)
Weak Sharpe Ratio (< 0.3)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
31.3%1 month
49.5%3 months
56.8%6 months
50.7%29.93
-
2.29
0.46
0.24
13.31
1.75
-
410.37M
5.13B
54.02M
-
3.78
260.00
21.30
7.86
-
-
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
Range10D
13.98
Range1M
23.10
Range3M
55.69
Rel. volume
0.26
Price X volume
3.00M
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Jagsonpal Pharmaceuticals Limited | JAGSNPHARM | Drug Manufacturers-Specialty & Generic | 203.04 | 5.39B | -0.20% | 61.65 | 4.77% |
| TAKE Solutions Limited | TAKE | Biotechnology | 29.57 | 4.37B | -0.34% | n/a | -417.95% |
| Bafna Pharmaceuticals Limited | BAFNAPH | Drug Manufacturers-Specialty & Generic | 176.34 | 4.19B | 10.00% | 674.92 | 30.17% |
| Albert David Ltd | ALBERTDAVD | Drug Manufacturers-Specialty & Generic | 710.75 | 4.07B | -1.21% | 9.51 | 0.87% |
| Medico Remedies Limited | MEDICO | Drug Manufacturers-Specialty & Generic | 45.52 | 3.62B | -0.85% | 45.53 | 15.37% |
| Medicamen Biotech Limited | MEDICAMEQ | Drug Manufacturers-Specialty & Generic | 245.65 | 3.03B | -3.93% | 82.74 | 15.37% |
| Kilitch Drugs (India) Limited | KILITCH | Drug Manufacturers-Specialty & Generic | 173.7 | 2.81B | -2.33% | 42.44 | 17.95% |
| Nectar Lifesciences Limited | NECLIFE | Drug Manufacturers-Specialty & Generic | 11.98 | 2.71B | 0.00% | 138.07 | 59.44% |
| Lyka Labs Limited | LYKALABS | Biotechnology | 63.57 | 2.27B | 5.32% | 813.94 | 86.05% |
| Aarey Drugs & Pharmaceuticals Limited | AAREYDRUGS | Drug Manufacturers-Specialty & Generic | 77.84 | 2.25B | 0.66% | 32.75 | 23.61% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Madhav Copper Limited | MCL | Copper | 59.6 | 1.64B | -0.28% | 82.22 | 32.14% |
| Cubex Tubings Limited | CUBEXTUB | Copper | 86.92 | 1.26B | -0.36% | 35.85 | 21.78% |
| Touchwood Entertainment Limited | TOUCHWOOD | Advertising Agencies | 70.46 | 785.54M | -2.29% | 50.06 | 4.88% |
| Sagardeep Alloys Limited | SAGARDEEP | Copper | 24.6 | 427.05M | -3.42% | 58.62 | 43.14% |
| Heads UP Ventures Limited | HEADSUP | Apparel Retail | 7.24 | 158.63M | 3.43% | n/a | 0.00% |
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | 13.31 | 24.85 | Cheaper |
| Ent. to Revenue | 1.75 | 11.40 | Cheaper |
| PE Ratio | 29.93 | 51.36 | Cheaper |
| Price to Book | 2.29 | 6.83 | Cheaper |
| Dividend Yield | - | 0.52 | - |
| Std. Deviation (3M) | 56.77 | 42.17 | Riskier |
| Debt to Equity | 0.46 | 0.35 | Expensive |
| Debt to Assets | 0.24 | 0.17 | Expensive |
| Market Cap | 5.13B | 290.82B | Emerging |